CSIMarket
 


Stryker Corp  (SYK)
Other Ticker:  
 
 

SYK's Capital Expenditures Growth by Quarter and Year

Stryker's Capital Expenditures results by quarter and year




SYK Capital Expenditures (in millions $) FY 2020 FY 2019 FY 2018 FY 2017
IV Quarter December 165.00 199.00 154.00 186.00
III Quarter September 69.00 163.00 297.00 142.00
II Quarter June 109.00 165.00 157.00 131.00
I Quarter March 144.00 122.00 121.00 139.00
FY   487.00 649.00 729.00 598.00



SYK Capital Expenditures forth quarter 2020 Y/Y Growth Comment
Stryker Corp reported decline in Capital Expenditures in the forth quarter by -17.09% to $ 165.00 millions, from the same quarter in 2019.
The contraction in the forth quarter Stryker Corp's Capital Expenditures compares unfavorably to the Company's average Capital Expenditures growth of 4.84%.

Looking into forth quarter results within Medical Equipment & Supplies industry 80 other companies have achieved higher Capital Expenditures growth. While Stryker Corp' s Capital Expenditures fall of -17.09% ranks overall at the positon no. 1625 in the forth quarter.




SYK Capital Expenditures ( Y/Y Growth %) 2020
2019 2018 2017
IV Quarter December -17.09 % 29.22 % -17.2 % 30.07 %
III Quarter September -57.67 % -45.12 % 109.15 % 20.34 %
II Quarter June -33.94 % 5.1 % 19.85 % -
I Quarter March 18.03 % 0.83 % -12.95 % 75.95 %
FY   -24.96 % -10.97 % 21.91 % 100 %

Financial Statements
Stryker's forth quarter 2020 Capital Expenditures $ 165.00 millions SYK's Income Statement
Stryker's forth quarter 2019 Capital Expenditures $ 199.00 millions Quarterly SYK's Income Statement
New: More SYK's historic Capital Expenditures Growth >>


SYK Capital Expenditures (Quarter on Quarter Growth %)

2020
2019 2018 2017
IV Quarter December 139.13 % 22.09 % -48.15 % 30.99 %
III Quarter September -36.7 % -1.21 % 89.17 % 8.4 %
II Quarter June -24.31 % 35.25 % 29.75 % -5.76 %
I Quarter March -27.64 % -20.78 % -34.95 % -2.8 %
FY (Year on Year)   -24.96 % -10.97 % 21.91 % 100 %




Capital Expenditures forth quarter 2020 Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #81
Healthcare Sector #310
Overall #1625

Capital Expenditures Y/Y Growth Statistics
High Average Low
109.15 % 4.84 % -100 %
(Sep 30 2018)   (Dec 31 2011)
Capital Expenditures forth quarter 2020 Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #81
Healthcare Sector #310
Overall #1625
Capital Expenditures Y/Y Growth Statistics
High Average Low
109.15 % 4.84 % -100 %
(Sep 30 2018)   (Dec 31 2011)

Capital Expenditures by Quarter for the Fiscal Years 2017, 2018, 2019, 2020

Stryker's Q/Q Capital Expenditures Growth


Capital Expenditures Q/Q Growth Statistics
High Average Low
139.13 % 12.46 % -100 %
(Dec 31 2020)  


SYK's IV. Quarter Q/Q Capital Expenditures Comment
Stryker Corp achieved in the IV. Quarter 2020 above company average sequential Capital Expenditures doubling of 139.13%, to $ 165.00 millions, from $69.00 millions in the third quarter.
Medical Equipment & Supplies company is undergoing a remarkable growth, with claiming above regular increase, but also improving pace.

Within Medical Equipment & Supplies industry 2 other companies have achieved higher Capital Expenditures quarter on quarter growth. While Stryker's Capital Expenditures growth quarter on quarter, overall rank is 61.


Capital Expenditures Q/Q Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #3
Healthcare Sector #13
Overall #61
Capital Expenditures Q/Q Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #3
Healthcare Sector #13
Overall #61
Capital Expenditures Q/Q Growth Statistics
High Average Low
139.13 % 12.46 % -100 %
(Dec 31 2020)  


SYK's IV. Quarter Q/Q Capital Expenditures Comment
Stryker Corp achieved in the IV. Quarter 2020 above company average sequential Capital Expenditures doubling of 139.13%, to $ 165.00 millions, from $69.00 millions in the third quarter.
Medical Equipment & Supplies company is impressively improving, with claiming higher then normal increase, and also improving rate, Devin Walsh, Healthcare sector veteran located in New York said.

Within Medical Equipment & Supplies industry 2 other companies have achieved higher Capital Expenditures quarter on quarter growth. While Stryker's Capital Expenditures growth quarter on quarter, overall rank is 61.


Stryker's 12 Months Capital Expenditures Growth Year on Year


Capital Expenditures TTM Growth

12 Months Ending
(Dec 31 2020)
12 Months Ending
(Sep 30 2020)
12 Months Ending
(Jun 30 2020)
12 Months Ending
(Mar 31 2020)
12 Months Ending
(Dec 31 2019)
Cumulative Capital Expenditures 12 Months Ending $ 487.00 $ 521.00 $ 615.00 $ 671.00 $ 649.00
Y / Y Capital Expenditures Growth (TTM) -24.96 % -13.74 % 5.85 % 17.1 % 13.46 %
Year on Year Capital Expenditures Growth Overall Ranking # 393 # 1542 # 1203 # 1069 # 1297
Seqeuential Capital Expenditures Change (TTM) -6.53 % -15.28 % -8.35 % 3.39 % 7.45 %
Seq. Capital Expenditures Growth (TTM) Overall Ranking # 374 # 2264 # 1884 # 1108 # 1068




Cumulative Capital Expenditures growth Comment
Stryker's cumulative 12 months Capital Expenditures continue to fall, but on the faster rate at -24.96% year on year, at Dec 31 2020 compare to the -13.74% decrease at Sep 30 2020. If the Stryker's fiscal year would end at Dec 31 2020, annual Capital Expenditures would be $487 millions.

In the Healthcare sector 46 other companies have achieved higher trailing twelve month Capital Expenditures growth. While Total ranking has impoved so far to 393, from total ranking in previous quarter at 1542.

Capital Expenditures TTM Q/Q Growth Statistics
High Average Low
119.61 %
8.23 %
-32.22 %
 

Capital Expenditures TTM Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 14
Healthcare Sector # 47
Overall # 393

Capital Expenditures TTM Y/Y Growth Statistics
High Average Low
190.16 %
30.43 %
-24.96 %
 


Capital Expenditures TTM Q/Q Growth Company Ranking
Within: No.
Industry # 14
Sector # 49
S&P 500 # 374
Cumulative Capital Expenditures growth Comment
Stryker's cumulative 12 months Capital Expenditures continue to fall, but on the faster rate at -24.96% year on year, at Dec 31 2020 compare to the -13.74% decrease at Sep 30 2020. If the Stryker's fiscal year would end at Dec 31 2020, annual Capital Expenditures would be $487 millions.

In the Healthcare sector 46 other companies have achieved higher trailing twelve month Capital Expenditures growth. While Total ranking has impoved so far to 393, from total ranking in previous quarter at 1542.

Capital Expenditures TTM Q/Q Growth Statistics
High Average Low
119.61 %
8.23 %
-32.22 %
 


Capital Expenditures TTM Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 14
Healthcare Sector # 47
Overall # 393

Capital Expenditures TTM Y/Y Growth Statistics
High Average Low
190.16 %
30.43 %
-24.96 %
 


Capital Expenditures TTM Q/Q Growth Company Ranking
Within: No.
Industry # 14
Sector # 49
S&P 500 # 374




Other Capital Expenditures Growth
Medical Equipment & Supplies Industry Capital Expenditures Growth Trends and Statistics
Healthcare Sector Capital Expenditures Growth Statistics
Capital Expenditures Growth Trends for overall market
SYK's Capital Expenditures Growth Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and total Market
Highest Ranking Capital Expenditures Growth
Lowest Ranking Capital Expenditures Growth
Capital Expenditures Growth for SYK's Competitors
Capital Expenditures Growth for Stryker's Suppliers
Capital Expenditures Growth for SYK's Customers

You may also want to know
SYK's Annual Growth Rates SYK's Profitability Ratios SYK's Asset Turnover Ratio SYK's Dividend Growth
SYK's Roe SYK's Valuation Ratios SYK's Financial Strength Ratios SYK's Dividend Payout Ratio
SYK's Roa SYK's Inventory Turnover Ratio SYK's Growth Rates SYK's Dividend Comparisons



Companies with similar Capital Expenditures fall for the quarter ending Dec 31 2020 within Healthcare SectorY/Y Change %Capital Expenditures for the quarter ending Dec 31 2020
Emergent Biosolutions Inc -0.28%$ -0.277 millions
Arrowhead Pharmaceuticals Inc -1.13%$ -1.128 millions
Bausch Health Companies Inc -1.18%$ -1.176 millions
Inogen Inc -1.65%$ -1.650 millions
Seres Therapeutics Inc -1.74%$ -1.739 millions
Nuvasive Inc-1.87%$ -1.866 millions
Cerus Corporation-1.89%$ -1.895 millions
Pra Health Sciences Inc -2.29%$ -2.293 millions
Steris Plc-3.12%$ -3.118 millions
Theravance Biopharma inc -4.53%$ -4.528 millions
Sientra inc -5.16%$ -5.163 millions
Zosano Pharma Corporation-5.48%$ -5.481 millions
Quest Diagnostics Inc-5.81%$ -5.814 millions
Taro Pharmaceutical Industries Ltd-7.40%$ -7.398 millions
Option Care Health Inc -7.52%$ -7.516 millions
Xeris Pharmaceuticals Inc -7.79%$ -7.787 millions
Amgen Inc -7.98%$ -7.979 millions
Zoetis Inc -8.43%$ -8.434 millions
Urogen Pharma Ltd -10.42%$ -10.417 millions
Gilead Sciences Inc -10.84%$ -10.837 millions
Evelo Biosciences Inc -11.66%$ -11.663 millions
Abbvie Inc -11.99%$ -11.987 millions
Fate Therapeutics inc -12.28%$ -12.278 millions
Tabula Rasa Healthcare inc -12.64%$ -12.635 millions
Abiomed Inc -12.78%$ -12.775 millions
Seagen Inc -13.06%$ -13.060 millions
Lemaitre Vascular Inc-13.21%$ -13.214 millions
Molecular Templates Inc -13.25%$ -13.253 millions
Phibro Animal Health Corp-13.29%$ -13.294 millions
Syneos Health Inc -13.59%$ -13.588 millions


Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

REZI's Profile

Stock Price

REZI's Financials

Business Description

Fundamentals

Charts & Quotes

REZI's News

Suppliers

REZI's Competitors

Customers & Markets

Economic Indicators

REZI's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Indices

Sectors & Industries

Financials

Commodities

Currencies

News


At a Glance

Stocks

Economy

Industries

Other

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.    Copyright © 2021 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071